A Persistent Foe: Reinvigorating the Fight against Cardiovascular Disease in a Changing World
Arun HS Kumar1
- 1Stemcology, School of Veterinary Medicine, University College Dublin, Belfield, Dublin, IRELAND..
Received: 10-04-2024; Revised: 15-04-2024; Accepted: 17-04-2024.
Volume 10, Issue 1 · pp. 21–23 · PUBLISHED · DOI: 10.5530/bems.10.1.5
ABSTRACT
For decades, Cardiovascular Disease (CVD) has cast a long shadow over humanity, claiming millions of lives each year. While advancements in medicine have yielded undeniable progress, a recent study published in The Lancet paints a disquieting picture.1 Life expectancy has undoubtedly improved globally,2 but a concerning stagnation in the decline of CVD mortality since 2009 demands our urgent attention. The study lays bare a fascinating paradox of our time. While it celebrates the undeniable progress in healthcare, it also unveils a hidden challenge. On the one hand, we witness a remarkable decline in mortality rates from previously dominant killers like stroke and lower respiratory infections.3,4 This translates into a demonstrably extended lifespan for the population. This progress speaks volumes about the positive impact of improved medical treatments and preventative measures.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Kumar, A. H. (). A Persistent Foe: Reinvigorating the Fight against Cardiovascular Disease in a Changing World. Biology, Engineering, Medicine and Science Reports, 10(1), 21–23. https://doi.org/10.5530/bems.10.1.5
